Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension

Basit Öğe Kaydı
dc.contributor.authorBayan, Kadim
dc.contributor.authorTuzun, Yekta
dc.contributor.authorYilmaz, Serif
dc.contributor.authorCanoruc, Naime
dc.contributor.authorDursun, Mehmet
dc.date.accessioned2024-04-24T16:02:21Z
dc.date.available2024-04-24T16:02:21Z
dc.date.issued2009
dc.departmentDicle Üniversitesien_US
dc.description.abstractIdiopathic portal hypertension (IPH) is characterized by non-cirrhotic presinusoidal intrahepatic portal hypertension. The etiopathogenesis of the disease is poorly understood. Obliteration with microthrombosis of the small portal vein branches may lead to lesions underlying portal hypertension. We aimed to put forward a comprehensive thrombophilic mutation profile in IPH and its probable contribution to pathogenesis. Eleven patients and 12 controls were included. We used the CVD-StripAssay which is based on the reverse-hybridization principle to identify a total of 12 thrombophilic gene mutations: Factor V R506Q, Factor V H1299R, prothrombin G20210A, Factor XIII V34L, beta-Fibrinogen -455 G-A, PAI-1 4G/5G, platelet GPIIIa L33P, MTHFR C677T, MTHFR A1298C, ACE I/D, Apo B R3500Q and Apo E2/E3/E4, respectively. We also evaluated some blood parameters and protein C, protein S, AT-III levels using commercially available assays. IPH patients and controls were similar in respect to gender distribution (P = 1.000). Mean age was 31.2 in patients and 29.1 in controls (P = 0.622). Pica history was present in 54.5% of the patients. Mean protein C and AT-III levels were lower in patients than that of controls (P = 0.002 and 0.001, respectively). Factor XIII V34L, PAI-1, GPIIIa L33P, MTHFR C677T and MTHFR A1298C frequencies of genetic polymorphisms were found to be significantly higher among patients than that of controls. Apolipoprotein E2/E3/E4 analysis showed an inverse relationship with IPH when E2 plus E4 compared with E3. A higher frequency of Beta-Fibrinogen -455G-A mutation was observed in patients, but this difference did not reach a statistical significance. Our data represent the most comprehensive study to date with respect to thrombophilic gene polymorphisms in IPH. The data support a possible pathogenetic role in IPH, at least by some of the prothrombotic mutations. In order to confirm or refuse this proposal, a larger cohort of patients is needed.en_US
dc.identifier.doi10.1007/s11239-008-0244-8
dc.identifier.endpage62en_US
dc.identifier.issn0929-5305
dc.identifier.issn1573-742X
dc.identifier.issue1en_US
dc.identifier.pmid18685811
dc.identifier.scopus2-s2.0-67449085330
dc.identifier.scopusqualityQ1
dc.identifier.startpage57en_US
dc.identifier.urihttps://doi.org/10.1007/s11239-008-0244-8
dc.identifier.urihttps://hdl.handle.net/11468/14756
dc.identifier.volume28en_US
dc.identifier.wosWOS:000266911900010
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Thrombosis and Thrombolysis
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIdiopathic Portal Hypertensionen_US
dc.subjectThrombophilic Mutationsen_US
dc.titleAnalysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertensionen_US
dc.titleAnalysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu